This inventor holds 5 USPTO granted patents, plus 1 CIPO patent. Top assignees: Nycomed Imaging as, 1C Targets as. Active years: 1994-2020.
Company Filing History:
Years Active: 1994-2020
Title: The Innovations of Per Jynge
Introduction
Per Jynge is a notable inventor based in Trondheim, Norway. He has made significant contributions to the field of medical imaging and treatment methodologies. With a total of 5 patents to his name, Jynge's work has the potential to impact healthcare positively.
Latest Patents
One of Jynge's latest patents focuses on magnetic resonance imaging (MRI). This method determines the amount of intracellular manganese in the myocardium of an individual who has been pre-administered with a manganese contrast agent. The procedure involves assessing the signal intensity of images or the longitudinal relaxation rate throughout the myocardium. Another significant patent involves the use of chelating agents in treating atherosclerotic conditions. This invention provides a therapeutic approach using dipyridoxyl or aminopolycarboxylic acid-based chelating agents, metal chelates, and their salts for the treatment or prophylaxis of atherosclerosis and related conditions in both humans and non-human animals.
Career Highlights
Throughout his career, Jynge has worked with prominent companies in the medical imaging sector. He has been associated with Nycomed Imaging and 1C Targets, where he contributed to advancements in imaging technologies and therapeutic solutions.
Collaborations
Jynge has collaborated with notable professionals in his field, including Robertson Towart and Jan Olof Gustav Karlsson. Their combined expertise has likely enhanced the quality and impact of their projects.
Conclusion
Per Jynge's innovative work in medical imaging and treatment methodologies showcases his dedication to improving healthcare. His patents reflect a commitment to advancing technology for better patient outcomes.